These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17331485)

  • 1. Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.
    Yang Q
    Cardiovasc Res; 2007 Apr; 74(1):4-5. PubMed ID: 17331485
    [No Abstract]   [Full Text] [Related]  

  • 2. Sphingosine-1-phosphate as a potential target for the treatment of myocardial infarction.
    Waeber C; Walther T
    Circ J; 2014; 78(4):795-802. PubMed ID: 24632793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shooting the messenger: oxidative stress regulates sphingosine-1-phosphate.
    Maceyka M; Milstien S; Spiegel S
    Circ Res; 2007 Jan; 100(1):7-9. PubMed ID: 17204658
    [No Abstract]   [Full Text] [Related]  

  • 4. C1q/TNF-related protein-1 functions to protect against acute ischemic injury in the heart.
    Yuasa D; Ohashi K; Shibata R; Mizutani N; Kataoka Y; Kambara T; Uemura Y; Matsuo K; Kanemura N; Hayakawa S; Hiramatsu-Ito M; Ito M; Ogawa H; Murate T; Murohara T; Ouchi N
    FASEB J; 2016 Mar; 30(3):1065-75. PubMed ID: 26578687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress-dependent sphingosine kinase-1 inhibition mediates monoamine oxidase A-associated cardiac cell apoptosis.
    Pchejetski D; Kunduzova O; Dayon A; Calise D; Seguelas MH; Leducq N; Seif I; Parini A; Cuvillier O
    Circ Res; 2007 Jan; 100(1):41-9. PubMed ID: 17158340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine-1-phosphate signaling in the cardiovascular system.
    Peters SL; Alewijnse AE
    Curr Opin Pharmacol; 2007 Apr; 7(2):186-92. PubMed ID: 17280869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An active lipid signaling molecule: sphingosine-1-phosphate and its biological characteristics].
    Yu Y; Qin SC
    Sheng Li Ke Xue Jin Zhan; 2011 Apr; 42(2):151-4. PubMed ID: 21770269
    [No Abstract]   [Full Text] [Related]  

  • 8. Sphingosine-1-phosphate in the circulatory system: Cause and therapeutic target for vascular dysfunction?
    Schubert R
    Cardiovasc Res; 2006 Apr; 70(1):9-11. PubMed ID: 16542647
    [No Abstract]   [Full Text] [Related]  

  • 9. Lipid metabolism: sources and stability of plasma sphingosine-1-phosphate.
    Jessup W
    Curr Opin Lipidol; 2008 Oct; 19(5):543-4. PubMed ID: 18769238
    [No Abstract]   [Full Text] [Related]  

  • 10. Deletion of the sphingosine kinase-1 gene influences cell fate during hypoxia and glucose deprivation in adult mouse cardiomyocytes.
    Tao R; Zhang J; Vessey DA; Honbo N; Karliner JS
    Cardiovasc Res; 2007 Apr; 74(1):56-63. PubMed ID: 17320845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingosine-1-phosphate: an enigmatic signalling lipid.
    Spiegel S; Milstien S
    Nat Rev Mol Cell Biol; 2003 May; 4(5):397-407. PubMed ID: 12728273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of ceramide in ischemic preconditioning.
    Cui J; Engelman RM; Maulik N; Das DK
    J Am Coll Surg; 2004 May; 198(5):770-7. PubMed ID: 15110811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Energy balance and the sphingosine-1-phosphate/ceramide axis.
    Green C; Mitchell S; Speakman J
    Aging (Albany NY); 2017 Dec; 9(12):2463-2464. PubMed ID: 29242408
    [No Abstract]   [Full Text] [Related]  

  • 14. [Function and metabolism of the bioactive lipid molecule sphingosine 1-phosphate].
    Kihara A; Iwaki S; Igarashi Y
    Tanpakushitsu Kakusan Koso; 2005 Sep; 50(11):1443-8. PubMed ID: 16146193
    [No Abstract]   [Full Text] [Related]  

  • 15. New aspects of sphingosine 1-phosphate signaling in mammalian cells.
    Pyne NJ; Long JS; Lee SC; Loveridge C; Gillies L; Pyne S
    Adv Enzyme Regul; 2009; 49(1):214-21. PubMed ID: 19534035
    [No Abstract]   [Full Text] [Related]  

  • 16. Interferon regulatory factor 9 is an essential mediator of heart dysfunction and cell death following myocardial ischemia/reperfusion injury.
    Zhang Y; Liu X; She ZG; Jiang DS; Wan N; Xia H; Zhu XH; Wei X; Zhang XD; Li H
    Basic Res Cardiol; 2014; 109(5):434. PubMed ID: 25150882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor.
    Theilmeier G; Schmidt C; Herrmann J; Keul P; Schäfers M; Herrgott I; Mersmann J; Larmann J; Hermann S; Stypmann J; Schober O; Hildebrand R; Schulz R; Heusch G; Haude M; von Wnuck Lipinski K; Herzog C; Schmitz M; Erbel R; Chun J; Levkau B
    Circulation; 2006 Sep; 114(13):1403-9. PubMed ID: 16982942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingosine kinase/sphingosine 1-phosphate signalling in central nervous system.
    Okada T; Kajimoto T; Jahangeer S; Nakamura S
    Cell Signal; 2009 Jan; 21(1):7-13. PubMed ID: 18694820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A polysaccharide, MDG-1, induces S1P1 and bFGF expression and augments survival and angiogenesis in the ischemic heart.
    Wang S; Zhang Z; Lin X; Xu DS; Feng Y; Ding K
    Glycobiology; 2010 Jan; 20(4):473-84. PubMed ID: 20008963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The natural cardioprotective particle HDL modulates connexin43 gap junction channels.
    Morel S; Frias MA; Rosker C; James RW; Rohr S; Kwak BR
    Cardiovasc Res; 2012 Jan; 93(1):41-9. PubMed ID: 21960685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.